SUGAR: Spherical Ultrafast Graph Attention Framework for Cortical Surface Registration
Authors:
Jianxun Ren,
Ning An,
Youjia Zhang,
Danyang Wang,
Zhenyu Sun,
Cong Lin,
Weigang Cui,
Weiwei Wang,
Ying Zhou,
Wei Zhang,
Qingyu Hu,
Ping Zhang,
Dan Hu,
Danhong Wang,
Hesheng Liu
Abstract:
Cortical surface registration plays a crucial role in aligning cortical functional and anatomical features across individuals. However, conventional registration algorithms are computationally inefficient. Recently, learning-based registration algorithms have emerged as a promising solution, significantly improving processing efficiency. Nonetheless, there remains a gap in the development of a lea…
▽ More
Cortical surface registration plays a crucial role in aligning cortical functional and anatomical features across individuals. However, conventional registration algorithms are computationally inefficient. Recently, learning-based registration algorithms have emerged as a promising solution, significantly improving processing efficiency. Nonetheless, there remains a gap in the development of a learning-based method that exceeds the state-of-the-art conventional methods simultaneously in computational efficiency, registration accuracy, and distortion control, despite the theoretically greater representational capabilities of deep learning approaches. To address the challenge, we present SUGAR, a unified unsupervised deep-learning framework for both rigid and non-rigid registration. SUGAR incorporates a U-Net-based spherical graph attention network and leverages the Euler angle representation for deformation. In addition to the similarity loss, we introduce fold and multiple distortion losses, to preserve topology and minimize various types of distortions. Furthermore, we propose a data augmentation strategy specifically tailored for spherical surface registration, enhancing the registration performance. Through extensive evaluation involving over 10,000 scans from 7 diverse datasets, we showed that our framework exhibits comparable or superior registration performance in accuracy, distortion, and test-retest reliability compared to conventional and learning-based methods. Additionally, SUGAR achieves remarkable sub-second processing times, offering a notable speed-up of approximately 12,000 times in registering 9,000 subjects from the UK Biobank dataset in just 32 minutes. This combination of high registration performance and accelerated processing time may greatly benefit large-scale neuroimaging studies.
△ Less
Submitted 2 July, 2023;
originally announced July 2023.
A deep belief network-based method to identify proteomic risk markers for Alzheimer disease
Authors:
Ning An,
Liuqi Jin,
Huitong Ding,
Jiaoyun Yang,
Jing Yuan
Abstract:
While a large body of research has formally identified apolipoprotein E (APOE) as a major genetic risk marker for Alzheimer disease, accumulating evidence supports the notion that other risk markers may exist. The traditional Alzheimer-specific signature analysis methods, however, have not been able to make full use of rich protein expression data, especially the interaction between attributes. Th…
▽ More
While a large body of research has formally identified apolipoprotein E (APOE) as a major genetic risk marker for Alzheimer disease, accumulating evidence supports the notion that other risk markers may exist. The traditional Alzheimer-specific signature analysis methods, however, have not been able to make full use of rich protein expression data, especially the interaction between attributes. This paper develops a novel feature selection method to identify pathogenic factors of Alzheimer disease using the proteomic and clinical data. This approach has taken the weights of network nodes as the importance order of signaling protein expression values. After generating and evaluating the candidate subset, the method helps to select an optimal subset of proteins that achieved an accuracy greater than 90%, which is superior to traditional machine learning methods for clinical Alzheimer disease diagnosis. Besides identifying a proteomic risk marker and further reinforce the link between metabolic risk factors and Alzheimer disease, this paper also suggests that apidonectin-linked pathways are a possible therapeutic drug target.
△ Less
Submitted 11 March, 2020;
originally announced March 2020.
